Modulation of glutathione conjugation in vivo: How to decrease glutathione conjugation in vivo or in intact cellular systems in vitro

Chemico-Biological Interactions

Volumn 105, Issue 1, 1997, Pages 17-34

  Mulder, Gerard J ^a   Ouwerkerk Mahadevan, Sivi ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIBROMOETHANE; BUTHIONINE SULFOXIMINE; ENZYME INHIBITOR; ETACRYNIC ACID; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE TRANSFERASE; MALEIC ACID DIETHYL ESTER; TIENILIC ACID;

ANIMAL EXPERIMENT; DETOXIFICATION; ENZYME INHIBITION; GLUTATHIONE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; REVIEW;

ANIMALIA;

EID: 0030789626     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00038-0     Document Type: Article

References (85)

1. Mannervik B. The isoenzymes of glutathione transferase. Adv. Enzymol. 57:1985;357-417.
2. B. Ketterer, G.J. Mulder, Glutathione Conjugation, in: G.J. Mulder (Ed.), Conjugation Reactions in Drug Metabolism, Taylor and Francis, London, 1990, pp. 307-364.
3. Commandeur J.N.M., Stijntjes G.J., Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Pharmacol. Revs. 47:1995;271-330.
4. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprevention and drug resistance. Crit. Revs Biochem. Mol. Biol. 30:1995;445-600.
5. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:1994;4313-4320.
6. Tew K.D., Monks A., Barone L., Rosser D., Akerman G., Montali J.A., Wheatley J.B., Schmidt D.E. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute drug screening program. Mol. Pharmacol. 50:1996;149-159.
7. Zaman G.J.R., Lamkelma J., van Tellingen O., Beijnen J., Dekker H., Paulusma C., Oude Elferink R.P.J., Baas F., Borst P. Role of glutathione in the export of compounds from cells by the multi-drug-resistance-associated protein. Proc. Natl. Acad. Sci USA. 92:1995;7690-7694.
8. Mannervik B., Danielson U.H. Glutathione transferases-structure and catalytic activity. CRC Crit. Revs Biochem. 23:1988;283-337.
9. Hayes J.D., Mantle T.J. Inhibition of hepatic and extrahepatic glutathione S-transferases by primary and secondary bile acids. Biochem. J. 233:1986;407-415.
10. Boyer T.D., Vessey D.A. Inhibition of human cationic glutathione S-transferase by nonsubstrate ligands. Hepatology. 7:1987;843-848.
11. Rompelberg C.J.M., Ploemen J.H.T.M., Jespersen S., van der Greef J., Verhagen H., van Bladeren P.J. Inhibition of rat, mouse, and human glutathione S-transferase by eugenol and its oxidation products. Chemico-Biological Interactions. 99:1996;85-97.
12. Zhang K., Das N.P. Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases. Biochem. Pharmacol. 47:1994;2063-2068.
13. Mosialou E., Morgenstern R. Activity of rat liver microsomal glutathione transferase toward products of lipid peroxidation and studies of the effect of inhibitors on glutathione-dependent protection against lipid peroxidation. Arch. Biochem. Biophys. 275:1989;289-294.
14. Berhane K., Widersten M., Engstrom A., Kozarich W., Mannervik B. Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. 91:1994;1480-1484.
15. K Ong L., Clark A.C. Inhibition of rat liver glutathione S-tansferases by glutathione conjugates and corresponding L-cysteines and mercapturic acids. Biochem. Pharmacol. 35:1986;651-654.
16. Clark A.G., Debnam P. Inhibition of glutathione S-transferases from rat liver by S-nitroso-L-glutathione. Biochem. Pharmacol. 37:1988;3199-3201.
17. Chen W.J., de Smidt P.C., Armstrong R.N. Stereoselective product inhibition of glutathione S- transferase. Biochem. Biophys. Res. Comm. 141:1986;892-897.
18. Ploemen J.H.T.M., Johnson W.W., Jesperson S., Vanderwall D., van Ommen B., van der Greef J., van Bladeren P.J., Armstrong R.N. Active-site tyrosyl residues are targets in the irreversible inhibition of a class mu glutathione transferase by 2-(S-glutathionyl)-3,5,6-trichloro-1,4-benzoquinone. J. Biol. Chem. 269:1994;26890-26897.
19. Cacurri A.M., Polizio F., Peimonte F., Tagliatesta P., Frederici G., Desideri A. Investigation of te active site of human placenta glutathione transferase π by means of spin-labelled glutathione analogue. Biochim. Biophys. Acta. 1122:1992;265-268.
20. Ploemen J.H.T.M., van Ommen B., van Bladeren P.J. Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate. Biochem. Pharmacol. 40:1990;1631-1635.
21. Ploemen J.H.T.M., van Ommen B., van Bladeren P.J. Irreversible inhibtion of human glutathione S-transferase isoenzymes by tetrachloro-1,4-benzoquinone and its glutathione conjugate. Biochem. Pharmacol. 41:1991;1665-1669.
22. van Ommen B., Ploemen J.H.T.M., Boogaards J.J.P., Monks T.J., Lau S.S., van Bladeren P.J. Irreversible inhibition of rat glutathione S-transferase 1-1 by quinones and their glutathione conjugates. Biochem. J. 276:1991;661-666.
23. Katusz R.M., Colman R.F. S-(4-bromo-2, 3-dioxobutyl)glutathione: a new affinity label for the 4-4 isoenzyme of rate liver glutathione S-transferase. Biochemistry. 30:1991;11230-11238.
24. 111 of glutathione S-transferase, isoenzyme 1-1, by S-(4-bromo-2,3-dioxobutyl)glutathione. Biochemistry. 31:1992;8984-8990.
25. Adang A.E.P., Moree W.J., Brussee J., Mulder G.J., van der Gen A. Inhibition of glutathione S-transferase 3-3 by glutathione derivatives that bind covalently to the active site. Biochem J. 278:1991;63-68.
26. Ploemen J.H.T.M., Boogaards J.J.P., Veldink G.A., van Ommen B., Jansen D.H.M., van Bladeren P.J. Isoenzyme selective irreversible inhibition of rat and human glutathione S-transferases by ethacrynic acid and two brominated derivatives. Biochem. Pharmacol. 45:1993;633-639.
27. Zheng J., Mitchell A.E., Jones A.D., Hammock B.D. Haloenol lactone is a new isoenzyme-selective and active site-directed inactivator of glutathione S-transferase. J. Biol. Chem. 271:1996;20421-20425.
28. Adang A.E.P., Brussee J., van der Gen A., Mulder G.J. Inhibition of rat liver glutathione S-transferase isoenzymes by peptides stabilized against degradation by γ-glutamyltranspeptidase. J. Biol. Chem. 266:1991;830-836.
29. Adang A.E.P., Brussee J., Meyer D.J., Coles B., Ketterer B., van der Gen A., Mulder G.J. Substrate specificity of rat liver glutathione S-transferase isoenzymes for a series of glutathione analogues, modified at the γ-glutamyl moiety. Biochem J. 255:1988;721-724.
30. Adang A.E.P., Meyer D.J., Brussee J., van der Gen A., Ketterer B., Mulder G.J. Interaction of rat glutathione S-transferases 7-7 and 8-8 with γ glutamyl or glycyl-modified glutathione analogues. Biochem J. 264:1989;759-764.
31. Adang A.E.P., Brussee J., van der Gen A., Mulder G.J. The glutathione binding site in glutathione S-transferases: investigation of the cysteinyl, glycyl and γ-glutamyl domains. Biochem. J. 269:1990;47-54.
32. Flatgaard J.R.E., Bauer K.E., Kauvar L.M. Isozyme specificity of novel glutathione-S-transferase inhibitors. Cancer Chemother. Pharmacol. 33:1993;63-70.
33. Lyttle M.H., Hocker M.D., Hui H.C., Caldwell C.G., Aaron D.T., Enquist-Goldstein A., Flatgaard J.E., Bauer K.E. Isozyme-specific glutathione S-transferase inhibitors: design and synthesis. J. Medicin. Chem. 37:1994;189-194.
34. Morgan A.S., Ciaccio P.J., Tew K.D., Kauvar L.M. Isozyme specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother. Pharmacol. 37:1996;363-370.
35. Ouwerkerk-Mahadevan S., van Boom J.H., Dreef-Tromp M.C., Ploemen J.H.T.M., Meyer D.J., Mulder G.J. Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and the rat in vivo. Biochem J. 308:1995;283-290.
36. Ouwerkerk-Mahadevan S., van Boom J.H., Mulder G.J. Isoenzyme-selective inhibition of glutathione conjugation in vivo: selective inhibition of the conjugation of S-2- bromoisovalerylurea in the rat. J. Pharmacol. Exp. Therap. 276:1996;923-928.
37. S. Ouwerkerk-Mahadevan, Ph.D. Thesis, Leiden University, 1997.
38. D'Silva C. Inhibition and recognition studies on the glutathione-binding site of equine liver glutathione S- transferase. Biochem. J. 271:1990;161-165.
39. Ploemen J.H.T.M., van Schanke A., van Ommen B., van Bladeren P.J. Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1. Cancer Res. 54:1994;915-919.
40. Takamatsu Y., Inaba T. Inhibition of human hepatic glutathione S-transferase isozymes by ethacrynic acid and its metabolites. Toxicology Letters. 62:1992;241-245.
41. 14C-busulfan in isolated perfused rat liver. Eur. J. Drug Metabol. Pharmacokin. 12:1987;71-76.
42. Tew K.D., Bomber A.M., Hoffmann S.J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 48:1988;3622-3625.
43. Clapper M.L., Hoffmann S.J., Tew K.D. Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid. J. Cell Pharmacol. 1:1990;71-78.
44. Hansson J., Berhane K., Castro V.M., Jungnelius U., Mannervik B., Ringsborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 51:1991;94-98.
45. van Iersel M.L.P.S., Ploemen J.P.H.T.M., Struik I., van Amersfoort C., Keyzer S.A.E., Schefferlie J.G., van Bladeren P.J. Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Chem. Biol. Interact. 102:1996;117-132.
46. Clapper M.L., Hofman S.J., D Tew K. Sensitization of human colon xenografts to L-phenylalanine mustard using ethacrynic acid. J. Cell Pharmacol. 1:1990;71-78.
47. Ciaccio P.J., Shien H., Jaiswal A.K., Lyttle M.H., Tew K.D. Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors. Mol.Pharmacol. 48:1995;639-647.
48. Ciaccio P.J., Sie H., Kruh G.D., Tew K.D. Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells. Biochem. Biophys. Res. Commun. 222:1996;111-115.
49. Kuzmich S., van der Veer L.A., Walsh E.S., LaCreta F.P., Tew K.D. Increased levels of glutathione-S-transferase Pi transcript as a mechanism of resistance to ethacrynic acid. Biochem. J. 281:1992;219-224.
50. Klaassen C.D., Fitzgerald T.J. Metabolism and biliary excretion of ethacrynic acid. J. Pharmacol. Exp Therap. 191:1974;548-556.
51. Wallin J.D., Clifton G., Kaplowitz N. The effect of phenobarbital, probenicid and diethylmaleate on the pharmacokinetics and biliary excretion of ethacrynic acid in the rat. J. Pharmacol. exp. Therap. 205:1978;471-476.
52. O'Dwyer P.J., LaCreta F., Nash S., Tinsley P.W., Schilder R., Clapper M.L., Tew K.D., Panting L., Litwin S., Comis R.L., Ozols R.F. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 51:1991;6059-6065.
53. Fehring S.I., Ahokas J.T. Effect of the glutathione S-transferase inhibitor, tienilic acid, on biliary excretion of sulphobromophthalein. Chem.-Biol. Interactions. 69:1989;23-32.
54. Aragno M., Tamagno E., Danni O., Chiarpotto E., Biasi F., Scavazzo A., Albano E., Poli G., Dianzani M.U. In vivo potentiation of 1,2-dibromoethane hepatotoxicity by ethanol through inactivation of glutathione-S-transferase. Chem. Biol. Interact. 99:1996;277-288.
55. Boyland E., Chasseaud L.F. The effect of some carbonyl compounds on rat liver glutathione levels. Biochem. Pharmacol. 19:1970;1526-1528.
56. R. van Doorn, C.M. Leijendekkers, P.T. Henderson, Synergistic effects of phorone on the hepatotoxicity of bromobenzene and paracetamol in mice, Toxicology, 11 (1978) 225-233.
57. Plummer J.L., Smith B.R., Sies H., Bend J.R. Chemical depletion of glutathione in vivo. Methods Enzymol. 77:1981;50-59.
58. Ecobichon D.J. Glutathione depletion and resynthesis in laboratory animals. Drug Chem. Toxicol. 7:1984;345-355.
59. D-Gerard-Monnier S., Fougeat, Chaudriere J. Glutathione and cystein depletion in rats and mice following acute intoxication with diethylmaleate. Biochem. Pharmacol. 43:1992;451-456.
60. Barnhart J.L., Combes B. Choleresis associated with metabolism and biliary excretion of diethyl maleate in the rat and the dog. J. Pharmacol. exp. Therap. 206:1978;614-623.
61. Wirth P.J., Thorgeirsson S.S. Glutathione synthesis and degradation in fetal and adult rat liver and Novikoff hepatoma. Cancer Res. 38:1978;2861-2865.
62. Polhuijs M., Lankhaar G., Mulder G.J. Relationship between glutathione content in liver and glutathione conjugation rate in the rat in vivo. Biochem. J. 285:1992;401-404.
63. Snel C.A.W., Pang K.S., Mulder G.J. Glutathione conjugation of bromosulfophthalein in relation to hepatic glutathione content in the rat in vivo and in the perfused rat liver. Hepatology. 21:1995;1387-1394.
64. Mulders T.M.T., Keizer H.J., Ouwerkerk J., van de Velde E.A., Breimer D.D., Mulder G.J. Effect of ifosfamide treatment on glutathione and glutathione conjugation activity in patients with advanced cancers. Clin. Cancer Res. 1:1995;1525-1536.
65. Lauterburg B.H., Nguyn T., Hartman B., Junker E., Kupfer A., Cerny T. Depletion of total cysteine, glutathione and homocysteine in plasma by ifosfamide/mesna therapy. Cancer Chemotherap. Pharmacol. 35:1994;132-136.
66. Griffith O.W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine. J. Biol. Chem. 254:1979;1979-1982.
67. Griffith O.W. Mechanism of action, metabolism and toxicity of buthionine sulfoximine and its higher homologues, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257:1982;13704-13712.
68. Drew R., Miners J.O. The effect of buthionine sulfoximine on glutathione depletion and xenobiotic biotransformation. Biochem. Pharmacol. 33:1984;2989-2994.
69. Manning B.W., Franklin M.R. Induction of rat UDP glucuronosyltransferase and glutathione S-transferase activities by L-buthionine sulfoximine without induction of cytochrome P450. Toxicology. 65:1990;149-159.
70. Shertzer H.G., Vasiliou V., Liu R.M., Tabor M.W., Nebert D.W. Enzyme induction by L-buthionine (SR) sulfoximine in cultured mouse hepatoma cells. Chem. Res. Toxicol. 8:1995;431-436.
71. Yao K.S., Godwin A.K., Ozols R.F., Hamilton T.C., O'Dwyer P.J. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients and its induction by buthionine sulfoximine treatment. Cancer Res. 53:1993;3662-3666.
72. Ali-Osman F., Antoun G., Wang H., Rajagopal S., Gagucas E. Buthionine sulfoximine induction of γ-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Mol. Pharmacol. 49:1996;1012-1020.
73. Yokomizo A., Kohno K., Wada M., Ono M., Morrow C.S., Cowant K.H., Kuwano K.M. Markedly decreased expression of glutathione S-transferase Pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. J. Biol. Chem. 270:1995;19451-19457.
74. Liebmann J.E., Hahn S.M., Cook J.A., Lipschultz C., Mitchell J.B., Kaufman D.C. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res. 53:1993;2066-2070.
75. Griffith O.W. Depletion of glutathione by inhibition of biosynthesis. Meth. Enzymol. 77:1981;59-63.
76. Sun J.D., Ragsdale S.S., Benson J.M., Henderson R.F. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S R-sulfoximine. Fund. Appl. Toxicol. 5:1985;913-919.
77. Ozols R.F., Louie K.G., Plowman J., Behrens B.C., Fine R.L., Dykes D., Hamilton T.C. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem. Pharmacol. 36:1987;147-153.
78. O'Dwyer P.J., Hamilton T.C., Young R.C., LaCreta F.P., Carp N., Tew K.D., Padavic K., Comis R.L., Ozols R.F. Depletion of glutathione in normal and malignant human cells in vivo by buthionine: clinical and biochemical results. J. natl. Cancer Instit. 84:1992;264-267.
79. O'Dwyer P.J., Hamilton T.C., LaCreta F.P., Gallo J.M., Kilppatrick D., Halbherr T., Brennan J., Bookman M.A., Hoffmann J., Young R.C., Comis R.L., Ozols R.F. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J. Clin. Oncol. 14:1996;249-256.
80. Bailey H.T., Mulcahy R.T., Ripple R.T., Tutsch K.P., Arzoomanian R.Z., Alberti D., Feierabend C., Mahvi D., Wilding G. Continuous infusion of buthionine sulfoximine and melphalan produces depletion of tumor glutathione to less than 10% of baseline in patients undergoing phase I treatment. Proc. ASCO. 14:1995;181.
81. Bailey H.T., Mulcahy R.T., Tutsch D.K., Azoomanian A.D., Tombes M.B., Wilding G., Pomplum M., Spriggs D.R. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J. Clin. Oncol. 12:1994;194-205.
82. LaCreta F.P., Brennan J.M., Jamilton T.C., Ozols R.F., O'Dwyer P.J. Stereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer. Drug Metabol. Disposit. 22:1994;835-842.
83. Gallo J.M., Brennan J., Hamilton T.C., Halbherr T., Laub P.B., Ozols R.F., O'Dwyer P.J. Time dependent pharmacokinetic models in cancer chemotherapy: population pharmacodynamic model for glutathione depeltion following modulation by buthionine sulfoximine in a phase I trial of melphalan and BSO. Cancer Res. 55:1995;4507-4511.
84. Thornally P.J., Ladan M.J., Ridgway S.J.S., Kang Y. Antitumor activity if S-(p-bromobenzyl)glutathione diesters in vitro: a structure activity study. J. Med. Chem. 39:1996;3409-3411.
85. Ban N., Takahashi Y., Takayama T., Kura T., Katahira T., Sakamaki S., Niitsu Y. Transfection of glutathione S-transferase GST-P antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan and etoposide. Cancer Res. 56:1996;3577-3582.